FIELD: chemistry.
SUBSTANCE: invention relates to field of biochemistry, in particular to methods for obtaining glycosylated conjugate of molecule with repeating motif for binding with antibody, which includes the following stages: 1) obtaining cells; 2) cultivation of cells; 3) separation of glycosylated conjugate of molecule with repeating motif from cells; 4) optional purification of separated glycosylated conjugate of molecule with repeating motif.
EFFECT: invention makes it possible to reduce content of by-products in the process of obtaining glycosylated conjugate of molecule with repeating motif.
5 cl, 19 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
CONJUGATE OF ANTIBODY AND DRUG, COMPOSITIONS BASED ON SAID CONJUGATE AND METHODS OF PRODUCING SAID CONJUGATE | 2015 |
|
RU2728235C2 |
HOMOGENEOUS ANTIBODY AND DRUG CONJUGATES PRODUCED BY ENZYMATIC METHODS | 2015 |
|
RU2796266C2 |
ALDEHYDE MARKED IMMUNOGLOBULIN POLYPEPTIDES AND METHODS OF THEIR APPLICATION | 2012 |
|
RU2606016C2 |
ANTI-MUC1 DRUG CONJUGATE | 2019 |
|
RU2804703C2 |
COMPOSITIONS AND METHODS OF USING FOR TREATING METABOLIC DISORDERS | 2014 |
|
RU2704285C2 |
COVALENTLY LINKED CONJUGATES CHELICAR-ANTIBODY AGAINST CHELICAR AND USE THEREOF | 2014 |
|
RU2694981C2 |
COMBINED THERAPY BASED ON AFUCOSYLATED CD20 ANTIBODY IN COMBINATION WITH CD22 ANTIBODY CONJUGATE - DRUG PREPARATION | 2014 |
|
RU2700092C2 |
ANTI-SEZ6 ANTIBODIES AND METHODS FOR USING THEM | 2013 |
|
RU2691698C2 |
COMBINATION THERAPY OF AFUCOSYLATED CD20 ANTIBODY WITH CD79b ANTIBODY-DRUGS CONJUGATE | 2014 |
|
RU2670971C9 |
BINDING MOLECULES, NAMELY ANTIBODIES CAPABLE OF BINDING TO L1CAM (CD171) | 2015 |
|
RU2754684C2 |
Authors
Dates
2016-02-10—Published
2010-11-04—Filed